You are using an older browser version. Please use a supported version for the best MSN experience.

Study: Orally administered drug 'TEMPOL' can inhibit COVID-19's replication

In a new study, a research team led by Dr. Tracey Rouault in the US National Institute of Child Health and Human Development (NICHD) has found new ways to target an enzyme produced by SARS-CoV-2 called RNA-dependent RNA polymerase (RdRp).
image beaconimage beaconimage beacon